Vein injections – how they work and what they are used for

Vein conditions, such as varicose veins and spider veins (also known as thread veins), can not only be unsightly but also cause discomfort and potentially serious health issues. Thankfully, advancements in medical technology have led to the development of minimally invasive, walk-in-walk-out vein injection treatments that eliminate the need for traditional and more invasive vein “stripping” procedures. In this article, Premier Veins will discuss two innovative techniques – Ultrasound-Guided Foam Sclerotherapy and Microsclerotherapy – including how they work and their effectiveness in providing relief to patients.

Ultrasound-Guided Foam Sclerotherapy (UGFS)

Ultrasound-Guided Foam Sclerotherapy, also known as VNUS Closure or ClosureFast, is a minimally invasive procedure designed to treat larger varicose veins (including those associated with chronic venous insufficiency (CVI)). These veins are often responsible for pain, swelling, and cosmetic concerns. It involves the injection of a special foam (called Fibrovein) into the affected veins under the guidance of ultrasound imaging. Typically performed under local anaesthetic in an outpatient setting, UGFS allows patients to return home on the same day, with an approx. treatment duration of one hour.

How it Works

  • Ultrasound Guidance: A vascular consultant uses ultrasound to accurately locate and guide the insertion of a small tube into the targeted varicose veins under local anaesthetic.
  • Preparation: The patient’s leg is raised to empty the veins and improve their visibility on the ultrasound.
  • Foam Preparation and Injection: A sclerosing agent is mixed with air to create a foam. This foam is injected through the tubes into the varicose veins, causing inflammation inside the vein, and leading to its closure.
  • Compression: After the injection, compression is applied to the area to facilitate vein closure and reduce the risk of complications. Over time, the body naturally absorbs the treated varicose vein and redirects blood flow to other healthier vessels.

For more information on UGFS click here >>

Microsclerotherapy

Microsclerotherapy is primarily used to treat spider veins, which are often associated with cosmetic concerns rather than significant symptoms. This outpatient procedure involves the injection of a sclerosing agent directly into the affected veins using a very fine needle. It is performed under no anaesthetic in an outpatient setting, meaning you will return home that same day. Microsclerotherapy takes approx. 45 minutes per leg.

How it Works

  • Assessment: The vascular consultant assesses the veins to be treated using a special vein light and marks them for injection.
  • Injection: Using a tiny needle, the sclerosing solution is injected directly into the targeted veins. The solution irritates the vein walls, causing them to stick together and eventually collapse.
  • Compression: After the injection, compression is applied to the treated area to facilitate vein closure and reduce the risk of complications.
  • Healing Process: Over time, the body naturally absorbs the collapsed veins, and blood is rerouted through other, existing healthier vessels.

For more information on Microsclerotherapy click here >>

It is clear that Ultrasound-Guided Foam Sclerotherapy and Microsclerotherapy are revolutionary procedures that provide patients with minimally invasive alternatives to traditional vein “stripping”. These techniques not only address cosmetic concerns but also provide symptomatic relief, improving the overall quality of life for patients diagnosed with varicose veins and spider veins. So, if you or anyone you know are suffering from these vascular conditions, talk to a member of Premier Veins's award-winning team for more information on UGFS and Microsclerotherapy, including pricing plans and their 12-month guarantee. Your journey to healthier and happier-looking legs starts with a conversation – it’s time to get your legs back to looking and feeling their best!

Powered by

LaingBuisson is the chosen provider of independent sector healthcare market data
to the UK Government’s Office for National Statistics.